Open Access
International Journal of Nanomedicine, pages 7371
Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles
Publication type: Journal Article
Publication date: 2015-12-10
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 8
ISSN: 11769114, 11782013
PubMed ID:
26677326
Organic Chemistry
Drug Discovery
General Medicine
Biophysics
Pharmaceutical Science
Bioengineering
Biomaterials
Citations by journals
|
1
2
|
|
|
Molecular Pharmaceutics
|
Molecular Pharmaceutics
2 publications, 40%
|
|
Drug development & registration
|
Drug development & registration
1 publication, 20%
|
|
Pharmaceutics
|
Pharmaceutics
1 publication, 20%
|
|
International Journal of Pharmaceutics
|
International Journal of Pharmaceutics
1 publication, 20%
|
|
1
2
|
Citations by publishers
|
1
2
|
|
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
2 publications, 40%
|
|
Center of Pharmaceutical Analytics Ltd
|
Center of Pharmaceutical Analytics Ltd
1 publication, 20%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 20%
|
|
Elsevier
|
Elsevier
1 publication, 20%
|
|
1
2
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2018,2019,2020,2021,2022],"ids":[0,0,0,0,0],"codes":[0,0,0,0,0],"imageUrls":["","","","",""],"datasets":[{"label":"Citations number","data":[1,2,0,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["20","40",0,"20","20"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Molecular Pharmaceutics","Drug development & registration","Pharmaceutics","International Journal of Pharmaceutics"],"ids":[19735,26766,4502,3305],"codes":[0,0,0,0],"imageUrls":["\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/ewwj5yBvA6wToa4jkXRrcDjN2omUCp6UYltwKhS8_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp"],"datasets":[{"label":"","data":[2,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[40,20,20,20],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["American Chemical Society (ACS)","Center of Pharmaceutical Analytics Ltd","Multidisciplinary Digital Publishing Institute (MDPI)","Elsevier"],"ids":[40,7156,202,17],"codes":[0,0,0,0],"imageUrls":["\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/ewwj5yBvA6wToa4jkXRrcDjN2omUCp6UYltwKhS8_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp"],"datasets":[{"label":"","data":[2,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[40,20,20,20],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Haddadi A., Jahan S. T. Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles // International Journal of Nanomedicine. 2015. p. 7371.
GOST all authors (up to 50)
Copy
Haddadi A., Jahan S. T. Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles // International Journal of Nanomedicine. 2015. p. 7371.
Cite this
RIS
Copy
TY - JOUR
DO - 10.2147/IJN.S90866
UR - https://doi.org/10.2147%2FIJN.S90866
TI - Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles
T2 - International Journal of Nanomedicine
AU - Haddadi, Azita
AU - Jahan, Sheikh Tasnim
PY - 2015
DA - 2015/12/10 00:00:00
PB - Dove Medical Press
SP - 7371
PMID - 26677326
SN - 1176-9114
SN - 1178-2013
ER -
Cite this
BibTex
Copy
@article{2015_Haddadi,
author = {Azita Haddadi and Sheikh Tasnim Jahan},
title = {Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles},
journal = {International Journal of Nanomedicine},
year = {2015},
publisher = {Dove Medical Press},
month = {dec},
url = {https://doi.org/10.2147%2FIJN.S90866},
pages = {7371},
doi = {10.2147/IJN.S90866}
}